Enavate Sciences Gp, LLC

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0001953107

Type: FundHoldings: 6Value: $132.7MLatest: 2025Q1

Enavate Sciences GP, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 6 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "CAMP",
  "ZBIO",
  "UPB",
  null,
  "IMNM",
  "CMPX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 6
Total Value: 132721569
Accession Number: 0001415889-25-013132
Form Type: 13F-HR
CIK: enavate-sciences-gp
Manager Name: Enavate-Sciences-Gp

Data Enrichment

83% identified

5 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

6 positions • $132.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Immunome Inc.

IMNM|45257U108

Shares:4.8M

Value:$32.1M

% of Portfolio:24.2% ($32.1M/$132.7M)

Zenas BioPharma, Inc.

ZBIO|98937L105

Shares:3.8M

Value:$29.7M

% of Portfolio:22.4% ($29.7M/$132.7M)

829401108

Shares:2.5M

Value:$25.9M

% of Portfolio:19.5% ($25.9M/$132.7M)

Camp4 Therapeutics Corp

CAMP|13463J101

Shares:3.8M

Value:$15.1M

% of Portfolio:11.4% ($15.1M/$132.7M)

Upstream Bio, Inc.

UPB|91678A107

Shares:2.5M

Value:$15.1M

% of Portfolio:11.3% ($15.1M/$132.7M)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:7.8M

Value:$14.8M

% of Portfolio:11.1% ($14.8M/$132.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Immunome Inc.(IMNMcusip45257U108)	4.8M	QoQ +37.09% (-1.3M) YoY-	All Managers (Combined)	$32.1M	24.2% ($32.1M/$132.7M)	QoQ -13.12% (-$4.8M) YoY-
Zenas BioPharma, Inc.(ZBIOcusip98937L105)	3.8M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$29.7M	22.4% ($29.7M/$132.7M)	QoQ -3.54% (-$1.1M) YoY-
(cusip829401108)✕	2.5M	QoQ NEW(+2.5M) YoY-	All Managers (Combined)	$25.9M	19.5% ($25.9M/$132.7M)	QoQ NEW(+$25.9M) YoY-
Camp4 Therapeutics Corp(CAMPcusip13463J101)	3.8M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$15.1M	11.4% ($15.1M/$132.7M)	QoQ -23.37% (-$4.6M) YoY-
Upstream Bio, Inc.(UPBcusip91678A107)	2.5M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$15.1M	11.3% ($15.1M/$132.7M)	QoQ -62.77% (-$25.4M) YoY-
Compass Therapeutics, Inc.(CMPXcusip20454B104)	7.8M	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$14.8M	11.1% ($14.8M/$132.7M)	QoQ +31.03% (+$3.5M) YoY-